Quick Answer
Werewolf Therapeutics, Inc. reported Net Income of -$60.82 million for fiscal year 2025.
Werewolf Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$60.82M | +13.7% |
| 2024 | -$70.52M | -88.7% |
| 2023 | -$37.37M | +30.6% |
| 2022 | -$53.81M | -7.7% |
| 2021 | -$49.98M | -232.3% |
| 2020 | -$15.04M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$16.37M | +1.8% | +9.0% |
| June 30, 2025 | -$17.98M | -4.2% | +0.6% |
| March 31, 2025 | -$18.09M | -11.7% | -8.5% |
| September 30, 2024 | -$16.67M | -101.2% | +3.3% |
| June 30, 2024 | -$17.25M | -238.3% | -6.5% |
| March 31, 2024 | -$16.19M | -35.1% | -95.4% |
| September 30, 2023 | -$8.29M | +30.6% | -62.5% |
| June 30, 2023 | -$5.10M | +65.1% | +57.5% |
- Werewolf Therapeutics, Inc. showed an increase of +13.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Werewolf Therapeutics, Inc.’s net income has declined by 304.4% (from -$15.04 million to -$60.82 million).
- The most recent figure is from Werewolf Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: